<DOC>
	<DOCNO>NCT01020136</DOCNO>
	<brief_summary>The purpose show 5 mg Form IV tablet AG-013736 produce similar drug concentration plasma compare 5 mg Form XLI tablet AG-013736 oral dose fed condition .</brief_summary>
	<brief_title>A Bioequivalence Study Of AG-013736 Tablets Under Fed Conditions In Healthy Volunteers</brief_title>
	<detailed_description>To establish bioequivalence Form IV Form XLI AG-013736 tablet</detailed_description>
	<mesh_term>Axitinib</mesh_term>
	<criteria>Healthy male and/or female subject age 21 47 year , inclusive ( Healthy define clinically relevant abnormality identify detailed medical history , full physical examination , include blood pressure pulse rate measurement , 12lead electrocardiogram ( ECG ) clinical laboratory test ) Body Mass Index ( BMI ) 17.5 30.5 kg/m2 ; total body weight &gt; 50 kg ( 110 lb ) An informed consent document sign date subject legally acceptable representative Evidence significant disease blood , kidney , endocrine system , lung , gastrointestinal , heart , liver , psychiatric , neurologic , allergic ( include drug allergy , exclude season allergy ) Use tobacco nicotine containing product ( positive urine cotinine test ) . Pregnant nursing female females childbearing potential include tubal ligation</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>47 Years</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Bioequivalence Pharmacokinetics</keyword>
</DOC>